Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: A new perspective from Rasch analysis

European Journal of Neurology

Volumn 17, Issue 2, 2010, Pages 273-279

  Forjaz, M J ^a   Ayala, A ^a   Rodriguez Blazquez, C ^b   Frades Payo, B ^b   Martinez Martin, P ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Differential item functioning; Internal construct validity; Parkinson's disease; Rasch analysis; SCOPA AUT

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; FEMALE; HUMAN; HYPERSALIVATION; IMPAIRED BLADDER EMPTYING; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PARKINSON DISEASE; PRIORITY JOURNAL; RASCH ANALYSIS; RATING SCALE; RELIABILITY; SCALE FOR OUTCOMES IN PARKINSON DISEASE FOR AUTONOMIC SYMPTOMS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 74549151055     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02835.x     Document Type: Article

References (23)

1. Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004 19 : 1306 1312.
2. Rasch G. Probabilistic Models for Some Intelligence and Attainment Tests. Expanded edition. Chicago : University of Chicago Press, 1980.
3. Grupo ELEP. A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology. Rev Neurol 2006 42 : 360 365.
4. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967 17 : 427 442.
5. Andrich D, Lyne A, Sheridon B, Luo G. RUMM2020. Perth : RUMM Laboratory, 2003.
6. Pallant JF, Tennant A. An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007 46 (Pt 1 1 18.
7. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007 57 : 1358 1362.
8. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's disease activity index. Rheumatology (Oxford) 2004 43 : 73 78.
9. Bond TG, Fox CM. Applying the Rasch Model: Fundamental Measurement in the Human Sciences. Mahwah, NJ : Lawrence Erlbaum Associates, Inc., 2001.
10. Smith EV Jr. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002 3 : 205 231.
11. Idiaquez J, Benarroch EE, Rosales H, Milla P, Rios L. Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res 2007 17 : 93 98.
12. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007 69 : 333 341.
13. Papapetropoulos S, Argyriou AA, Chroni E. No correlation between the clinical severity of autonomic symptoms (SCOPA-AUT) and electrophysiological test abnormalities in advanced Parkinson's disease. Mov Disord 2006 21 : 430 431.
14. Cubo E, Martinez P, Gonzalez M, Frades B. Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease. Neurologia 2008 24 : 15 23.
15. Martinez-Martin P, Arroyo S, Rojo-Abuin JM, Rodriguez-Blazquez C, Frades B, de Pedro CJ. Burden, perceived health status, and mood among caregivers of Parkinson's disease patients. Mov Disord 2008 23 : 1673 1680.
16. Evatt ML, Chaudhuri KR, Chou KL, et al. Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation-Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord 2009 24 : 635 646.
17. Fisher W Jr. Reliability statistics. Rasch Measurement Transactions 1992 6 : 238.
18. Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro J, Martinez-Martin P. Independent validation of the Scales for Outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol 2010 17 : 194 201.
19. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006 21 : 916 923.
20. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters. Neurourol Urodyn 2009 28 : 510 515.
21. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007 22 : 1623 1629.
22. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007 22 : 1901 1911.
23. Perez LS, Piran AG, Rossi M, Caivano Nemet ML, Salsamendi P, Merello M. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord 2007 22 : 107 111.